Shares of TriMas Corp (NASDAQ:TRS) have been given a consensus rating of “Hold” by the eight research firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $26.83.

Several analysts have recently commented on the company. BidaskClub cut TriMas from a “hold” rating to a “sell” rating in a report on Wednesday. ValuEngine upgraded TriMas from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research upgraded TriMas from a “hold” rating to a “buy” rating and set a $31.00 target price on the stock in a report on Monday, January 22nd. Finally, Deutsche Bank set a $29.00 target price on TriMas and gave the stock a “hold” rating in a report on Friday, January 19th.

In other news, CFO Robert J. Zalupski sold 2,816 shares of the company’s stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $25.94, for a total transaction of $73,047.04. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Joshua A. Sherbin sold 13,828 shares of the company’s stock in a transaction on Monday, November 20th. The shares were sold at an average price of $25.50, for a total value of $352,614.00. The disclosure for this sale can be found here. Corporate insiders own 1.40% of the company’s stock.

Institutional investors and hedge funds have recently modified their holdings of the company. Great West Life Assurance Co. Can lifted its stake in shares of TriMas by 114.4% during the third quarter. Great West Life Assurance Co. Can now owns 6,790 shares of the industrial products company’s stock valued at $183,000 after acquiring an additional 3,623 shares during the period. First Quadrant L P CA acquired a new position in shares of TriMas during the fourth quarter valued at $195,000. Cigna Investments Inc. New acquired a new position in shares of TriMas during the fourth quarter valued at $212,000. Thompson Siegel & Walmsley LLC acquired a new position in shares of TriMas during the third quarter valued at $227,000. Finally, SG Americas Securities LLC acquired a new position in shares of TriMas during the third quarter valued at $228,000. 97.32% of the stock is currently owned by institutional investors and hedge funds.

Shares of TriMas (NASDAQ TRS) opened at $24.50 on Friday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.33 and a current ratio of 2.67. The company has a market capitalization of $1,122.45, a price-to-earnings ratio of -34.03, a PEG ratio of 3.08 and a beta of 1.94. TriMas has a 1-year low of $19.75 and a 1-year high of $28.85.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this story can be viewed at https://www.dailypolitical.com/2018/02/10/trimas-corp-trs-given-average-rating-of-hold-by-analysts.html.

TriMas Company Profile

TriMas Corporation is a designer, manufacturer and distributor of engineered products for commercial, industrial and consumer markets. The Company operates through four segments: Packaging, Aerospace, Energy and Engineered Components. The Packaging segment is a designer, manufacturer and distributor of engineered closure and dispensing systems for a range of end markets, including steel and plastic industrial, and consumer packaging applications.

Analyst Recommendations for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.